Chifeng, China

Shousong Cao

This inventor holds 1 USPTO granted patent. Top assignee: Yuliang Li. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shousong Cao. Retrieved from https://idiyas.com/inventor/shousong-cao-bj68ev7m

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Shousong Cao

Introduction: Shousong Cao, an accomplished inventor based in Chifeng, China, has made notable advancements in the field of pharmaceuticals. With a focus on anti-tumor drugs, Cao's work exemplifies the intersection of innovation and medical research.

Latest Patents: Shousong Cao holds a significant patent for a "Compound of camptothecin and preparation and use thereof." This patent details a compound with promising applications as an anti-tumor drug, highlighting the importance of his contribution to cancer treatment. The compound's formula and its pharmaceutical composition provide essential insights into its effectiveness in combating tumor growth.

Career Highlights: Throughout his career, Shousong Cao has showcased a dedication to developing innovative solutions in the pharmaceutical sector. His patent represents a significant stride in cancer research, demonstrating his capability as an inventor and his commitment to enhancing medical therapies.

Collaborations: Notable collaborations have marked Shousong Cao's professional journey. He has worked alongside esteemed colleagues, including Yuliang Li and Huting Wang, contributing to research that bridges various aspects of pharmaceuticals and drug development.

Conclusion: Shousong Cao is a distinguished inventor whose work in creating valuable pharmaceutical compounds reflects his expertise and dedication to improving cancer treatment. His innovative spirit and collaborative efforts continue to advance the field, making him an important figure in the landscape of modern medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…